Vigil Neuroscience Inc
NASDAQ:VIGL
Vigil Neuroscience Inc
NASDAQ:VIGL
Price:
3.18 USD
-0.63%
Market Closed
Updated:
Jun 1, 2024
Vigil Neuroscience Inc
Net Issuance of Common Stock
|
Vigil Neuroscience Inc
Net Issuance of Common Stock Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Vigil Neuroscience Inc
NASDAQ:VIGL
|
Net Issuance of Common Stock
$911k
|
CAGR 3-Years
-67%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Net Issuance of Common Stock
-$1.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
37%
|
CAGR 10-Years
-18%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Issuance of Common Stock
-$719m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
22%
|
CAGR 10-Years
-2%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Issuance of Common Stock
-$288.7m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Issuance of Common Stock
-$473.2m
|
CAGR 3-Years
51%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Vigil Neuroscience Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
911k
USD
911k
USD
Based on the financial report for Dec 31, 2023, Vigil Neuroscience Inc's Net Issuance of Common Stock amounts to 911k USD.
What is Vigil Neuroscience Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 3Y
-67%
-67%
Over the last year, the Net Issuance of Common Stock growth was -99%. The average annual Net Issuance of Common Stock growth rates for Vigil Neuroscience Inc have been -67% over the past three years .
You don't have any saved screeners yet
